O. Alison Potok

O. Alison Potok

Auto-generated profile, based on publicly available information

O. Alison Potok

Division of Nephrology-Hypertension, University of California San Diego, San Diego, California

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2020 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
OPO. Alison Potok
O. Alison Potok
JIJoachim H. Ix
Joachim H. Ix
MSMichael G. Shlipak
Michael G. Shlipak
RKRonit Katz
Ronit Katz
AHAmret T. Hawfield
Amret T. Hawfield
DRDena E. Rifkin
Dena E. Rifkin

16 July 2020 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
OPO. Alison Potok
O. Alison Potok
RKRonit Katz
Ronit Katz
NBNisha Bansal
Nisha Bansal
DSDavid S. Siscovick
David S. Siscovick
MOMichelle C. Odden
Michelle C. Odden
DRDena E. Rifkin
Dena E. Rifkin

13 March 2023 in Kidney Medicine
Verified
Journal Article
Open access
OPO. Alison Potok
O. Alison Potok
DRDena E. Rifkin
Dena E. Rifkin
JIJoachim H. Ix
Joachim H. Ix
MSMichael G. Shlipak
Michael G. Shlipak
ASAnita Satish
Anita Satish
NENatalie Ebert
Natalie Ebert
Serum creatinine and cystatin C are used to estimate glomerular filtration rate, but creatinine-based estimated glomerular filtration rate (eGFRcr), cystatin C–based estimated glomerular filtration rate (eGFRcys), and combined creatinine- and cystatin C–based estimated glomerular filtration rate (eGFRcr-cys) are often divergent, particularly in older adults. We investigated which estimated glomerular filtration rate (eGFR) was more accurate and less biased compared with measured glomerular filtration rate (mGFR). A diagnostic test study from the Berlin Initiative Study. The study population included 657 individuals aged 70 years or older with iohexol plasma clearance (mGFR) and serum creatinine and cystatin C measurements: 567 community-dwelling participants and 90 with a serum creatinine of ≥1.5 mg/dL. We defined 3 groups on the basis of the difference eGFRcys − eGFRcr: whether < −5 mL/min/1.73 m2 (lower eGFRcys), within 5 mL/min/1.73 m2 (reference), or ≥ 5 mL/min/1.73 m2 (lower eGFRcr). eGFRcr, eGFRcys, and eGFRcr-cys were compared to mGFR to assess bias and accuracy. Median bias (eGFR minus mGFR) with 95% CIs and accuracy (percentage of eGFR values within ±30% of mGFR). The mean ± standard deviation age was 78 ± 6 years; the mean eGFRcys, eGFRcr, and eGFRcr-cys were 59 ± 23, 64 ± 20, and 61 ± 22 mL/min/1.73 m2, respectively, and the mean mGFR was 56 ± 19 mL/min. Half of the participants were in the lower eGFRcys group (n=337, 51%). Among them, the median bias for eGFRcys was the lowest (median bias, −2.7; 95% CI, −3.8 to −1.9) compared with the other eGFR equations. Conversely, in the lower eGFRcr group (n=121, 18%), the median bias for eGFRcr was the lowest compared with those for eGFRcys and eGFRcr-cys (2.9; [95% CI, 0.9-4.8] vs 13.8 [95% CI, 11.4-15.6] and 9.5 [95% CI, 7.7-11.0], respectively). Accuracy (percentage of eGFR values within ±30% of mGFR) was 93% for eGFRcr in the lower eGFRcr group and 92% for eGFRcys and 94% for eGFRcr-cys in the lower eGFRcys group. Untested generalizability in younger populations. Among older adults, the lower eGFR between eGFRcys and eGFRcr was a more accurate and less biased estimate of mGFR when comparing the groups.

25 January 2022 in Kidney Medicine
Verified
Journal Article
Open access
PDF file
OPO. Alison Potok
O. Alison Potok
JIJoachim H. Ix
Joachim H. Ix
MSMichael G. Shlipak
Michael G. Shlipak
NBNisha Bansal
Nisha Bansal
RKRonit Katz
Ronit Katz
DRDena E. Rifkin
Dena E. Rifkin
Rationale & Objective The difference in estimated glomerular filtration rate between cystatin C and creatinine (eGFRDiff) is known to be associated with frailty and mortality. Creatinine is influenced by muscle mass, more so than cystatin C; we aimed to determine whether eGFRDiff is associated with muscle quantity and to what extent muscle quantity explains the relationship between eGFRDiff and poor functional status. Study Design A cohort analysis of the Health, Aging, and Body Composition study (HABC) Setting & Participants 2970 HABC participants had baseline serum creatinine, cystatin C, and body composition measures on imaging. Exposure EGFRs calculated using CKD-EPI equations (eGFRCys and eGFRCr), and eGFRDiff calculated as eGFRCys – eGFRCr. Outcomes Total thigh muscle area was evaluated on computed tomography. Physical performance battery (HABCPPB) was scored on a continuous scale (standing and walking tasks); poor functional status defined as the lowest quartile. Analytical Approach We used linear regression to model the cross-sectional association of eGFRDiff and muscle measures. We used logistic regression to evaluate the association of eGFRDiff with poor functional status. Results Mean age was 74 (±3) years, eGFRCys, eGFRCr, eGFRDiff were 72 (±18), 68 (±15), and 4 (±14) mL/min/1.73m Shlipak M.G. Mattes M.D. Peralta C.A. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis. 2013; 62 : 595-603 https://doi.org/10.1053/j.ajkd.2013.03.027 Abstract Full Text Full Text PDF PubMed Scopus (132) Google Scholar respectively. Compared to participants in the reference group (-10<eGFRDiff≤10 mL/min/1.73m Shlipak M.G. Mattes M.D. Peralta C.A. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis. 2013; 62 : 595-603 https://doi.org/10.1053/j.ajkd.2013.03.027 Abstract Full Text Full Text PDF PubMed Scopus (132) Google Scholar ), those in the negative eGFRDiff group (≤ -10 mL/min/1.73m Shlipak M.G. Mattes M.D. Peralta C.A. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis. 2013; 62 : 595-603 https://doi.org/10.1053/j.ajkd.2013.03.027 Abstract Full Text Full Text PDF PubMed Scopus (132) Google Scholar ) were more likely to have comorbidities, slower gait and worse functional status. They had approximately 14cm Shlipak M.G. Mattes M.D. Peralta C.A. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis. 2013; 62 : 595-603 https://doi.org/10.1053/j.ajkd.2013.03.027 Abstract Full Text Full Text PDF PubMed Scopus (132) Google Scholar smaller thigh muscle area, in the fully adjusted model. Compared to the reference group, those in the negative group had 1.89-fold higher odds of poor functional status (unadjusted). This relationship was minimally attenuated after adjustment for thigh muscle, thigh fat area, appendicular lean mass, and limb fat mass, individually and in combination. Limitations Functional status outcome specific to HABC. Muscle measures do not capture dynamic turnover. Conclusions The difference eGFRCys - eGFRCr provides information on older adults’ functional status, which is only partially explained by muscle quantity and quality.

11 February 2025 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
SHStein Hallan
Stein Hallan
MØMarius A. Øvrehus
Marius A. Øvrehus
MSMichael G. Shlipak
Michael G. Shlipak
OPO. Alison Potok
O. Alison Potok
SRSolfrid Romundstad
Solfrid Romundstad
KLKnut A. Langlo
Knut A. Langlo
Key Points: Physical exercise mitigates several kidney-related pathophysiological pathways, yet its effect on kidney function remains underexplored. This randomized clinical trial found that high-intensity interval training significantly reduced the risk of rapid eGFR decline in older adults. Physical exercise can preserve kidney function, benefiting public health and individual patient outcomes similar to other cardiovascular diseases. Background: CKD is a growing global public health issue. Physical exercise mitigates several kidney-related pathophysiological pathways, yet its effect on kidney function remains underexplored. We investigated the dose-response effect of physical exercise on kidney function preservation in older adults. Methods: We conducted a post hoc analysis of the Generation 100 Study, a 5-year open-label, randomized, parallel-arm clinical trial conducted from 2012 to 2018 in Trondheim, Norway. All inhabitants aged 70–77 years were invited ( n =6966). Main exclusion criteria were dementia; severe, uncontrolled cardiovascular disease or hypertension; or conditions precluding exercise. The control group ( n =385) received information on national physical activity recommendations. Intervention groups underwent supervised moderate-intensity continuous training (70% of peak heart rate) for 50 minutes ( n =380) twice weekly for 5 years or high-intensity interval training (90% of peak heart rate) for 4 minutes ×4 ( n =391) twice weekly for 5 years. The primary outcome was cystatin C–based rapid eGFR decline (>5 ml/min per 1.73 m 2 per year). Results: A total of 1156 participants were randomized, with median (interquartile range) age 72 (3) years and eGFR 95 (20) ml/min per 1.73 m 2 . Oxygen uptake increased by 1.8, 2.3, and 3.3 ml/kg per minutes in the control, moderate-intensity, and high-intensity groups, respectively. Rapid eGFR decline occurred in 117 (30%), 108 (28%), and 92 (23%) participants, respectively. Compared with controls, relative risk (RR) was 0.93 (95% confidence interval [CI], 0.75 to 1.16) for the moderate-intensity and 0.75 (95% CI, 0.59 to 0.95) for high-intensity groups, demonstrating a significant dose-response relationship ( P for trend 0.02). In observational analyses, participants with decreasing moderate-to-vigorous intensity activity (>−20 min/wk) had RR 1.30 (95% CI, 0.93 to 1.83) for rapid eGFR decline, while those with increasing activity (>+20 min/wk) had RR 0.73 (95% CI, 0.53 to 0.99) compared with stable activity after adjusting for baseline age, sex, peak oxygen uptake, and eGFR. Conclusions: High-intensity interval training significantly reduced the risk of rapid eGFR decline in older adults. Clinical Trial registry name and registration number: ClinicalTrials.gov: NCT01666340.

21 January 2023 in American Journal of Kidney Diseases
Verified
Journal Article
Open access
PDF file
CCClarkson Crane
Clarkson Crane
RCRobyn A. Cunard
Robyn A. Cunard
NSNatalie Sweiss
Natalie Sweiss
NSNicholas Scanlon
Nicholas Scanlon
TDTaylor A. Doherty
Taylor A. Doherty
OPO. Alison Potok
O. Alison Potok
Hypersensitivity reactions to ethylene oxide (EtO) sterilized dialyzers have been well described. While EtO is no longer used to sterilize most dialyzers, it is used on other pieces of dialysis equipment. We present a case of a 78-year-old male who suffered dialysis-related anaphylaxis attributed to an IgE-mediated allergy to EtO-sterilized dialysis tubing and needles. Shortly after transitioning from a tunneled catheter to an arteriovenous fistula, he developed multiple episodes of intradialytic hypotension and syncope within minutes of starting dialysis. Laboratory evaluation revealed marked leukocytosis, eosinophilia and elevated anti-EtO IgE antibody. Following pre-treatment with corticosteroids and antihistamines, rinsing of dialysis tubing, and transition of access back to a tunneled catheter, he tolerated subsequent dialysis treatments. Review of his history revealed chronic eosinophilia since the time of hemodialysis initiation. We hypothesize his eosinophilia and mast cell degranulation began upon initial exposure to EtO and hemodialysis equipment. When use of the arteriovenous fistula was resumed, he was exposed to a higher “dose” of EtO due to use of needles. The higher antigenic stimuli triggered memory immune response leading to mast cell degranulation and repeated anaphylactic episodes that were overcome by minimization of EtO sterilized equipment, corticosteroid pretreatment and the anti-IgE Fc monoclonal, omalizumab.